British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent ...

Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin ...

David Por joins the firm’s Paris team as partner | New hire brings two decades of experience, including in healthcare and ...

The former USPTO director has filed her first amicus brief since rejoining private practice, arguing that instructions issued ...